Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

British Journal of Cancer

Volumn 92, Issue 10, 2005, Pages 1906-1914

  Cheng, H L ^a   Liu, H S ^a   Lin, Y J ^a   Chen, H H W ^a   Hsu, P Y ^a   Chang, T Y ^a   Ho, C L ^a   Tzai, T S ^a   Chow, N H ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bladder cancer; Co expression; MET; Prognosis; Protein tyrosine kinases; RON

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; COMPLEMENTARY DNA; DOXORUBICIN; EPIRUBICIN; MESSENGER RNA; METHOTREXATE; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; THIOTEPA; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR RON; UNCLASSIFIED DRUG; VINBLASTINE; WORTMANNIN; RON PROTEIN; SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL VIABILITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MET GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN URINE LEVEL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RON GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING; WOUND HEALING; BIOSYNTHESIS; BLADDER TUMOR; COHORT ANALYSIS; GENE EXPRESSION PROFILING; GENETICS; MACROPHAGE; PATHOLOGY; POLYMERASE CHAIN REACTION; SURVIVAL;

CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; GENE EXPRESSION PROFILING; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 20344392876     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602593     Document Type: Article

References (31)

1. Adam RM, Roth JA, Cheng HL, Rice DC, Khoury J, Bauer SB, Peters CA, Freeman MR (2003) Signaling through PDK/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells. J Urol 169: 2388-2393
2. Angeloni D, Danilkovitch-Miagkova A, Ivanov SV, Breathnach R, Johnson BE, Leonard EJ, Lerman MI (2000) Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples. Genes Chromosomes Cancer 29: 147-156, doi: 10.1002/1098-2264 (2000)9999:9999 〈 ::AID-GCC1015 〉 3.0.CO;2-N
3. Chen Q, Seol DW, Carr B, Zarnegar R (1997) Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology 26: 59-66, doi: 10.1002/ hep.510260108
4. Chen YQ, Zhou YQ, Fisher JH, Wang MH (2002) Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo. Oncogens 21: 6382-6386, doi: 10.1038/sj.onc.1205783
5. Cheng HL, Trink B, Tzai TS, Liu HS, Chan SH, Ho CL, Sidransky D, Chow NH (2002) Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder. A comparison with p53 nuclear accumulation. J Clin Oncol 20: 1544-1550
6. Chow NH, Chan SH, Tzai TS, Ho CL, Liu HS (2001) Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. Clin Cancer Res 7: 1957-1962
7. Chow NH, Lin YJ, Cheng HL, Tzai TS, Ho CL, Chang TY, Dai YC, Liu HS (2003) The significance of macrophage stimulating protein (MSP)/RON signaling pathway in the progression of human bladder cancer. Proc Am Assoc Cancer Res 44: 397 (abstract)
8. Collesi C, Santoro MM, Gaudino G, Comoglio PM (1996) A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol Cell Biol 16: 5518-5526
9. Crew JP, O'Brien T, Bradburn M, Fuggle S, Bicknell R, Cranston D, Harris AL (1997) Vascular endothelial growth factor is predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57: 5281-5285
10. Danilkovitch A, Donley S, Skeel A, Leonard EJ (2000) Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol Cell Biol 20: 2218-2227
11. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press
12. Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM (2000) Cross-talk between the proto-oncogenes Met and Ron. Oncogene 19: 3041-3049
13. Heldin CH (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223
14. Ho CL, Tsai YC, Hsu YH, Chen HW, Liu HS, Chang YC, Chow NH (2005) Mini chamber system for long-term maintenance and observation of cultured cells. Biotechniques 38: 267-273
15. Holmang S, Hedelin H, Anderstrom C, Johansson SL (1995) The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 153: 1823-1827
16. Koo SH, Kwon KC, Ihm CH, Jeon YM, Park JW, Sul CK (1999) Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet Cytogenet 110: 87-93, doi: 10.1016/S0165-4608(98)00193-9
17. Maggiora P, Lorenzato A, Fracchioli S, Costa B, Castagnaro M, Arisio R, Katsaros D, Massobrio M, Comoglio PM, Flavia Di Renzo M (2003) The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness. Exp Cell Res 288: 382-389, doi: 10.1016/S0014-4827(03) 00250-7
18. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M, Di Renzo MF, Costantino A, Sismondi P, Comoglio PM (1998) Overexpression of the RON gene in human breast carcinoma. Oncogene 16: 2927-2933
19. Peace BE, Hughes MJ, Degen SJ, Waltz SE (2001) Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20: 6142-6151
20. Pinkas-Kramarski R, Shelly M, Glathe S, Ratzkin BJ, Yarden Y (1996) Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. J Biol Chem 271: 19029-19032
21. Rampino T, Collesi C, Gregorini M, Maggio M, Soccio G, Guallini P, Dal Canton A (2002) Macrophage-stimulating protein is produced by tubular cells and activates mesangial cells. J Am Soc Nephrol 13: 649-657
22. Ronsin C, Muscatelli F, Mattei MG, Breathnach R (1993) A novel putative receptor protein tyrosine kinase of the met family. Oncogene 8: 1195-1202
23. Rossi MR, Masters JR, Park S, Todd JH, Garrett SH, Sens MA, Somji S, Nath J, Sens DA (2001) The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect 109: 801-808
24. Santoro MM, Collesi C, Grisendi S, Gaudino G, Comoglio PME (1996) Constitutive activation of the RON gene promotes invasive growth but not transformation. Mol Cell Biol 16: 7072-7083
25. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin of bladder cancer. N Engl J Med 326: 737-740
26. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway III KL (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661-14665
27. Sobin LH, Wittekind C (2002) UICC TNM Classification of Malignant Tumours. New York: Wiley-Liss
28. Wada T, Qian XL, Greene MI (1990) Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function. Cell 61: 1339-1347
29. Wang MH, Ronsin C, Gesnel MC, Coupey L, Skeel A, Leonard EJ, Breathnach R (1994) Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266: 117-119
30. Yan L, Borregaard N, Kjeldsen L, Moses MA (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265
31. Zhou YQ, He C, Chen YQ, Wang D, Wang MH (2003) Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential. Oncogene 22: 186-197, doi: 10.1038/ sj.onc.1206075.